Evidence map›Paper›PMID 41471174›Full record

ArticlePathogens (Basel, Switzerland)2025

Association of Antimicrobial Susceptibility with Treatment Response in

Xuejiao Luo, Yuhang Chen, Lina Davies Forsman, Yifan He, Guoling Yang, Wei Wei, Hai Lou, Li Wang, Lan Yao, Yidian Liu and 5 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pathogens (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Xuejiao LuoClinic and Research Centre of Tuberculosis, Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai 200433, China.
Yuhang ChenSchool of Exercise and Health, Shanghai University of Sport, Shanghai 200438, China.ORCID 0000-0001-6352-4002
Lina Davies ForsmanDivision of Infectious Diseases, Department of Medicine, Karolinska Institute, 17177 Stockholm, Sweden.
Yifan HeClinic and Research Centre of Tuberculosis, Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai 200433, China.
Guoling YangClinic and Research Centre of Tuberculosis, Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai 200433, China.
Wei WeiClinic and Research Centre of Tuberculosis, Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai 200433, China.
Hai LouClinic and Research Centre of Tuberculosis, Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai 200433, China.
Li WangClinic and Research Centre of Tuberculosis, Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai 200433, China.ORCID 0009-0007-0035-8220
Lan YaoClinic and Research Centre of Tuberculosis, Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai 200433, China.
Yidian LiuClinic and Research Centre of Tuberculosis, Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai 200433, China.
Judith BruchfeldDivision of Infectious Diseases, Department of Medicine, Karolinska Institute, 17177 Stockholm, Sweden.
Jan-Willem AlffenaarFaculty of Medicine and Health, School of Pharmacy, The University of Sydney, Sydney, NSW 2006, Australia.ORCID 0000-0001-6703-0288
Biao XuDepartment of Epidemiology, School of Public Health and Key Laboratory of Public Health Safety, Fudan University, Shanghai 200030, China.ORCID 0000-0001-8695-7396
Xubin ZhengClinic and Research Centre of Tuberculosis, Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai 200433, China.
Wei ShaClinic and Research Centre of Tuberculosis, Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai 200433, China.

Funding

Key Technologies Research and Development Program 2023YFC2307300Key Technologies Research and Development Program 2023YFC2307305National Natural Science Foundation of China 82204107Shanghai Municipal Health Commission 20234Y0251Shanghai Municipal Health Commission GWVI-11·2-YQ06
6 · The paper itself

Abstract

Understanding the clinical implications of minimum inhibitory concentration (MIC) may facilitate optimal drug selection in

Indexed as

Anti-Bacterial AgentsLung DiseasesMycobacterium avium ComplexMycobacterium avium-intracellulare InfectionAdultAgedChinaClarithromycinEthambutolFemaleHumansMaleMicrobial Sensitivity TestsMiddle AgedRetrospective StudiesTreatment OutcomeAnti-Bacterial AgentsClarithromycinEthambutolminimum inhibitory concentrationMycobacterium avium complexpulmonary diseasetreatment outcome

Identifiers

PMID41471174
PMCPMC12736129

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.